Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that CEO and Managing Director Riccardo Canevari and Executive Chairman Paul Hopper will conduct an investor webinar to provide an update following…
True North Copper Limited (ASX: TNC) (TNC or the Company) is pleased to announce mining operations at its Wallace…
CleanTech Lithium PLC (AIM:CTL, Frankfurt:T2N, OTCQX:CTLHF), an exploration and development company advancing lithium projects in Chile, is pleased to…
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) is pleased to advise that on 28…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of…
In the tech space this week, two financial institutions applied to offer exchange-traded funds (ETFs) tied to the spot…
Freegold Ventures Limited (TSX: FVL) (Frankfurt: FR4N) (‘Freegold’, the Company) today announced that all matters set out in the…
(TheNewswire) Vancouver, BC June 28, 2024 TheNewswire Coniagas Battery Metals Inc. (TSXV: COS) announces that it will effect a…
(TheNewswire) Vancouver, BC, June 28, 2024 TheNewswire Silver North Resources Ltd. (TSX-V: SNAG, OTCQB: TARSF) ‘ Silver North ‘…